Guardant Health

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

1. HeadlineBetween 5 January 2025 and 3 July 2026

   BeforeShield ™ Is Finally Here

   AfterConquering Cancer With Data

   Observed on the company’s website; business claims are not independently verified.

   earlier archived pagelater archived pageLink to observation
2. ComplianceBetween 7 July 2023 and 5 January 2025

   Now states FDA APPROVED compliance on its homepage.

   Observed on the company’s website; business claims are not independently verified.

   earlier archived pagelater archived pageLink to observation
3. HeadlineBetween 7 July 2023 and 5 January 2025

   BeforeTransforming cancer care at all stages of the disease

   AfterShield ™ Is Finally Here

   Observed on the company’s website; business claims are not independently verified.

   earlier archived pagelater archived pageLink to observation
4. ComplianceBetween 2 July 2020 and 2 January 2022

   Now states FDA APPROVED and FDA-APPROVED compliance on its homepage.

   Observed on the company’s website; business claims are not independently verified.

   earlier archived pagelater archived pageLink to observation
5. HeadlineBetween 31 July 2018 and 2 July 2020

   BeforeGuardant Health

   AfterA simple blood draw helps cancer patients get the right drug.

   Observed on the company’s website; business claims are not independently verified.

   earlier archived pagelater archived pageLink to observation
6. HiringBetween 1 February 2014 and 17 July 2015

   Added a careers page.

   Observed on the company’s website; business claims are not independently verified.

   earlier archived pagelater archived pageLink to observation
7. MessagingBetween 16 September 2012 and 1 February 2014

   BeforeGuardant Health: Home

   AfterGuardant Health: Tracking Cancer in Real Time

   Classifier interpretation of website text.

   earlier archived pagelater archived pageLink to observation

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

1. July 2026 – November 2026 · 2 captures · latest observed messagingConquering Cancer With Data

   Guardant Health is a leading precision medicine company focused on transforming patient care and conquering cancer with data.

   This wording observed 6 November 2026.

   current websiteHistorical capture not publicly available
   Inspect 2 captures in this group

   • 3 July 2026 · Conquering Cancer With Data archived page
   • 6 November 2026 · Conquering Cancer With Data current websiteHistorical capture not publicly available
2. Seen January 2025 · 1 captureShield ™ Is Finally Here

   Guardant Health is a leading precision medicine company focused on transforming patient care and conquering cancer with data.

   This wording observed 5 January 2025.

   archived page
3. Seen July 2023 · 1 captureTransforming cancer care at all stages of the disease

   Transforming cancer care at all stages of the disease AJ Patel 7-year stage IV lung cancer survivor Transforming cancer care at all

   This wording observed 7 July 2023.

   archived page
4. Seen January 2022 · 1 captureGuardant Health – Conquering Cancer with Data | Guardant Health

   […]

   This wording observed 2 January 2022.

   archived page
5. Seen July 2020 · 1 captureA simple blood draw helps cancer patients get the right drug.

   We’re developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

   This wording observed 2 July 2020.

   archived page
6. September 2012 – February 2014 · 2 capturesGuardant Health: Tracking Cancer in Real Time

   This wording observed 1 February 2014.

   archived page
   Inspect 2 captures in this group

   • 16 September 2012 · Guardant Health: Home archived page
   • 1 February 2014 · Guardant Health: Tracking Cancer in Real Time archived page

Companies in the same space

Competitors picked by an AI model from the funded startups with the most similar descriptions, judged on those descriptions only. A reading, not a verified market map.

• AccuraGen, Inc. accuragen.comDirect competitorBoth develop liquid biopsy ctDNA assays to guide personalized cancer treatment and monitoring.
• Predicine predicine.comDirect competitorBoth offer liquid biopsy genomic profiling and analytics for oncology care and drug development.
• GeneCentric genecentric.comDirect competitorBoth sell precision oncology liquid biopsy tests from blood to profile tumors and guide therapy.
• Precede Biosciences precede.bioPartial overlapBoth provide blood-based liquid biopsy and data platforms supporting biomarker-driven cancer drug development.
• GRAIL grail.comPartial overlapBoth develop blood-based liquid biopsy tests using circulating nucleic acids for cancer detection.
• Nucleix nucleix.comPartial overlapBoth market non-invasive liquid biopsy ctDNA tests and analytics for cancer detection and monitoring.
• Foresight Diagnostics foresight-dx.comDirect competitorBoth commercialize ultra-sensitive ctDNA liquid biopsy assays for MRD and cancer monitoring.
• mDETECT mdetect-inc.comPartial overlapBoth offer blood-based ctDNA assays to monitor cancer progression, relapse and therapy response.